Your browser doesn't support javascript.
loading
Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications.
Döhner, Hartmut; Weber, Daniela; Krzykalla, Julia; Fiedler, Walter; Wulf, Gerald; Salih, Helmut; Lübbert, Michael; Kühn, Michael W M; Schroeder, Thomas; Salwender, Hans; Götze, Katharina; Westermann, Jörg; Fransecky, Lars; Mayer, Karin; Hertenstein, Bernd; Ringhoffer, Mark; Tischler, Hans-Joachim; Machherndl-Spandl, Sigrid; Schrade, Anika; Paschka, Peter; Gaidzik, Verena I; Theis, Frauke; Thol, Felicitas; Heuser, Michael; Schlenk, Richard F; Bullinger, Lars; Saadati, Maral; Benner, Axel; Larson, Richard; Stone, Richard; Döhner, Konstanze; Ganser, Arnold.
Afiliación
  • Döhner H; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Weber D; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Krzykalla J; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
  • Fiedler W; Hubertus Wald University Cancer Center, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Wulf G; Department of Hematology and Oncology, Georg-August-University Göttingen, Göttingen, Germany.
  • Salih H; Department of Hematology and Oncology, Eberhard-Karls University, Tübingen, Germany.
  • Lübbert M; Department of Medicine I, Medical Center - University of Freiburg, Freiburg, Germany.
  • Kühn MWM; Department of Hematology, Medical Oncology & Pneumology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Schroeder T; Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Salwender H; Department of Oncology and Hematology, Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg, Germany.
  • Götze K; Department of Medicine III, Hematology and Medical Oncology, Technical University of Munich, Munich, Germany.
  • Westermann J; Department of Hematology, Oncology and Tumorimmunology, Charité University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany.
  • Fransecky L; Department of Internal Medicine II, University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany.
  • Mayer K; Department of Hematology, Oncology, University Hospital Bonn, Bonn, Germany.
  • Hertenstein B; Department of Hematology and Oncology, Klinikum Bremen-Mitte, Bremen, Germany.
  • Ringhoffer M; Department of Internal Medicine III, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.
  • Tischler HJ; Department of Hematology and Oncology, University Hospital of Minden, Minden, Germany.
  • Machherndl-Spandl S; Department of Hematology and Oncology, Hospital Elisabethinen Linz, Linz, Austria.
  • Schrade A; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Paschka P; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Gaidzik VI; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Theis F; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Thol F; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Schlenk RF; National Center of Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.
  • Bullinger L; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Saadati M; Department of Hematology, Oncology and Tumorimmunology, Charité University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany.
  • Benner A; Freelance Statistician, Saadati Solutions, Ladenburg, Germany.
  • Larson R; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
  • Stone R; Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, IL; and.
  • Döhner K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Ganser A; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
Blood Adv ; 6(18): 5345-5355, 2022 09 27.
Article en En | MEDLINE | ID: mdl-35486475
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos